← Back to headlines
Vertex Completes Rolling BLA Submission for Povetacicept
Vertex Pharmaceuticals has announced the completion of its rolling Biologics License Application (BLA) submission for povetacicept.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
